Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Yu, K-S
199  Ergebnisse:
Personensuche X
?
1

An Accelerator Mass Spectrometry‐Enabled Microtracer Study ..:

Kim, A ; Yu, B‐Y ; Dueker, SR...
Clinical Pharmacology & Therapeutics.  102 (2017)  3 - p. 537-546 , 2017
Link: https://doi.org/10.1002/..
 
?
2

Exploration of Biomarkers for Amoxicillin/Clavulanate-Induc..:

Lee, J ; Ji, SC ; Kim, B...
Clinical and Translational Science.  10 (2016)  3 - p. 163-171 , 2016
Link: https://doi.org/10.1111/..
 
?
3

Combined untargeted and targeted metabolomic profiling reve..:

Cho, K. ; Moon, J. S. ; Kang, J‐H....
Pediatric Obesity.  12 (2016)  2 - p. 93-101 , 2016
Link: https://doi.org/10.1111/..
 
?
4

Response to "Induction of both P‐glycoprotein and specific ..:

Oh, J ; Ji, SC ; Lee, H..
Clinical Pharmacology & Therapeutics.  97 (2015)  4 - p. 325-325 , 2015
Link: https://doi.org/10.1002/..
 
?
5

Aspirin Decreases Systemic Exposure to Clopidogrel Through ..:

Oh, J ; Shin, D ; Lim, K S...
Clinical Pharmacology & Therapeutics.  95 (2014)  6 - p. 608-616 , 2014
Link: https://doi.org/10.1038/..
 
?
6

Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A..:

Shin, K-H ; Choi, M H ; Lim, K S...
Clinical Pharmacology & Therapeutics.  94 (2013)  5 - p. 601-609 , 2013
Link: https://doi.org/10.1038/..
 
?
7

Prolonged Use of Aspirin Alters Human and Rat Intestinal Ce..:

Jung, K-H ; Chu, K ; Lee, S-T...
Clinical Pharmacology & Therapeutics.  90 (2011)  4 - p. 612-619 , 2011
Link: https://doi.org/10.1038/..
 
?
8

Pharmacokinetic and Pharmacodynamic Interaction of Lorazepa..:

Chung, J-Y ; Cho, J-Y ; Yu, K-S...
Clinical Pharmacology & Therapeutics.  83 (2007)  4 - p. 595-600 , 2007
Link: https://doi.org/10.1038/..
 
?
9

Modeling of Brain D2 Receptor Occupancy-Plasma Concentratio..:

Lim, K S ; Kwon, J S ; Jang, I-J...
Clinical Pharmacology & Therapeutics.  81 (2007)  2 - p. 252-258 , 2007
Link: https://doi.org/10.1038/..
 
?
10

Microstructural investigation of low temperature chemical v..:

Lee, B-T. ; Kim, D-K. ; Moon, C-K....
Journal of Materials Research.  14 (1999)  1 - p. 24-28 , 1999
Link: https://doi.org/10.1557/..
 
?
11

PDB60 DEVELOPMENT AND EVALUATION OF THE ASK ADHERENCE BARRI..:

Yu-Isenberg, KS ; Espindle, DM ; Skinner, EP...
Value in Health.  8 (2005)  6 - p. A173 , 2005
Link: https://doi.org/10.1016/..
 
?
12

PAO1 CARDIORENAL EFFECTS AND COSTS OF COX-2 INHIBITORS IN A..:

Yu-Isenberg, KS ; Leslie, RS ; Chang, EY..
Value in Health.  5 (2002)  3 - p. 177 , 2002
Link: https://doi.org/10.1016/..
 
?
13

PAO2 TREATMENT PATTERNS OF CARE AND THE RISK OF SUBSEQUENT ..:

Yu-Isenberg, KS ; Ventura, EP ; Chang, EY...
Value in Health.  5 (2002)  3 - p. 177-178 , 2002
Link: https://doi.org/10.1016/..
 
?
14

Development of a Fast Onset Proton Pump Inhibitor: Comparis..:

Bae S ; Kwon J ; Lee MH..
https://www.dovepress.com/development-of-a-fast-onset-proton-pump-inhibitor-comparison-of-fixed--peer-reviewed-fulltext-article-DDDT.  , 2023
Link: https://doaj.org/article..
 
?
15

Comparison of the Pharmacokinetics, Safety, and Tolerabilit..:

Jiang X ; Bae S ; Yoon DY...
https://www.dovepress.com/comparison-of-the-pharmacokinetics-safety-and-tolerability-of-two-empa-peer-reviewed-fulltext-article-DDDT.  , 2023
Link: https://doaj.org/article..
 
1-15